193 related articles for article (PubMed ID: 19394687)
1. Differential proteomics analysis of the surface heterogeneity of dextran iron oxide nanoparticles and the implications for their in vivo clearance.
Simberg D; Park JH; Karmali PP; Zhang WM; Merkulov S; McCrae K; Bhatia SN; Sailor M; Ruoslahti E
Biomaterials; 2009 Aug; 30(23-24):3926-33. PubMed ID: 19394687
[TBL] [Abstract][Full Text] [Related]
2. Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: mechanisms and comparison of ferumoxides and ferumoxtran-10.
Raynal I; Prigent P; Peyramaure S; Najid A; Rebuzzi C; Corot C
Invest Radiol; 2004 Jan; 39(1):56-63. PubMed ID: 14701989
[TBL] [Abstract][Full Text] [Related]
3. Role of carbohydrate receptors in the macrophage uptake of dextran-coated iron oxide nanoparticles.
Chao Y; Karmali PP; Simberg D
Adv Exp Med Biol; 2012; 733():115-23. PubMed ID: 22101717
[TBL] [Abstract][Full Text] [Related]
4. Different effect of hydrogelation on antifouling and circulation properties of dextran-iron oxide nanoparticles.
Karmali PP; Chao Y; Park JH; Sailor MJ; Ruoslahti E; Esener SC; Simberg D
Mol Pharm; 2012 Mar; 9(3):539-45. PubMed ID: 22243419
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of complement activation by dextran-coated superparamagnetic iron oxide (SPIO) nanoworms in mouse versus human serum.
Banda NK; Mehta G; Chao Y; Wang G; Inturi S; Fossati-Jimack L; Botto M; Wu L; Moghimi SM; Simberg D
Part Fibre Toxicol; 2014 Nov; 11():64. PubMed ID: 25425420
[TBL] [Abstract][Full Text] [Related]
6. A model of lysosomal metabolism of dextran coated superparamagnetic iron oxide (SPIO) nanoparticles: implications for cellular magnetic resonance imaging.
Arbab AS; Wilson LB; Ashari P; Jordan EK; Lewis BK; Frank JA
NMR Biomed; 2005 Oct; 18(6):383-9. PubMed ID: 16013087
[TBL] [Abstract][Full Text] [Related]
7. Hepatic cellular distribution and degradation of iron oxide nanoparticles following single intravenous injection in rats: implications for magnetic resonance imaging.
Briley-Saebo K; Bjørnerud A; Grant D; Ahlstrom H; Berg T; Kindberg GM
Cell Tissue Res; 2004 Jun; 316(3):315-23. PubMed ID: 15103550
[TBL] [Abstract][Full Text] [Related]
8. Magnetic labeling of non-phagocytic adherent cells with iron oxide nanoparticles: a comprehensive study.
Boutry S; Brunin S; Mahieu I; Laurent S; Vander Elst L; Muller RN
Contrast Media Mol Imaging; 2008; 3(6):223-32. PubMed ID: 19072771
[TBL] [Abstract][Full Text] [Related]
9. In vitro model of bromodeoxyuridine or iron oxide nanoparticle uptake by activated macrophages from labeled stem cells: implications for cellular therapy.
Pawelczyk E; Arbab AS; Chaudhry A; Balakumaran A; Robey PG; Frank JA
Stem Cells; 2008 May; 26(5):1366-75. PubMed ID: 18276802
[TBL] [Abstract][Full Text] [Related]
10. Lysosomal degradation of the carboxydextran shell of coated superparamagnetic iron oxide nanoparticles and the fate of professional phagocytes.
Lunov O; Syrovets T; Röcker C; Tron K; Nienhaus GU; Rasche V; Mailänder V; Landfester K; Simmet T
Biomaterials; 2010 Dec; 31(34):9015-22. PubMed ID: 20739059
[TBL] [Abstract][Full Text] [Related]
11. [Preparation and characterization of superparamagnetic iron oxide nanoparticles].
Liu ST; Yan Y; Chen ZL; Zhang YZ; Jin X
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar; 26(3):331-4. PubMed ID: 16546740
[TBL] [Abstract][Full Text] [Related]
12. Variability of Complement Response toward Preclinical and Clinical Nanocarriers in the General Population.
Benasutti H; Wang G; Vu VP; Scheinman R; Groman E; Saba L; Simberg D
Bioconjug Chem; 2017 Nov; 28(11):2747-2755. PubMed ID: 29090582
[TBL] [Abstract][Full Text] [Related]
13. Physical and biological characterization of superparamagnetic iron oxide- and ultrasmall superparamagnetic iron oxide-labeled cells: a comparison.
Sun R; Dittrich J; Le-Huu M; Mueller MM; Bedke J; Kartenbeck J; Lehmann WD; Krueger R; Bock M; Huss R; Seliger C; Gröne HJ; Misselwitz B; Semmler W; Kiessling F
Invest Radiol; 2005 Aug; 40(8):504-13. PubMed ID: 16024988
[TBL] [Abstract][Full Text] [Related]
14. Surface properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil.
Jung CW
Magn Reson Imaging; 1995; 13(5):675-91. PubMed ID: 8569442
[TBL] [Abstract][Full Text] [Related]
15. Superparamagnetic iron oxide nanoparticle probes for molecular imaging.
Thorek DL; Chen AK; Czupryna J; Tsourkas A
Ann Biomed Eng; 2006 Jan; 34(1):23-38. PubMed ID: 16496086
[TBL] [Abstract][Full Text] [Related]
16. Biodegradation of magnetite dextran nanoparticles in the rat. A histologic and biophysical study.
Okon E; Pouliquen D; Okon P; Kovaleva ZV; Stepanova TP; Lavit SG; Kudryavtsev BN; Jallet P
Lab Invest; 1994 Dec; 71(6):895-903. PubMed ID: 7807971
[TBL] [Abstract][Full Text] [Related]
17. Methods for magnetically labeling stem and other cells for detection by in vivo magnetic resonance imaging.
Frank JA; Anderson SA; Kalsih H; Jordan EK; Lewis BK; Yocum GT; Arbab AS
Cytotherapy; 2004; 6(6):621-5. PubMed ID: 15773025
[TBL] [Abstract][Full Text] [Related]
18. Direct recognition of superparamagnetic nanocrystals by macrophage scavenger receptor SR-AI.
Chao Y; Karmali PP; Mukthavaram R; Kesari S; Kouznetsova VL; Tsigelny IF; Simberg D
ACS Nano; 2013 May; 7(5):4289-98. PubMed ID: 23614696
[TBL] [Abstract][Full Text] [Related]
19. Cell internalization of magnetic nanoparticles using transfection agents.
Montet-Abou K; Montet X; Weissleder R; Josephson L
Mol Imaging; 2007; 6(1):1-9. PubMed ID: 17311760
[TBL] [Abstract][Full Text] [Related]
20. Nanovectors for anticancer agents based on superparamagnetic iron oxide nanoparticles.
Douziech-Eyrolles L; Marchais H; Hervé K; Munnier E; Soucé M; Linassier C; Dubois P; Chourpa I
Int J Nanomedicine; 2007; 2(4):541-50. PubMed ID: 18203422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
